12/22/2025
Contrast-enhanced US showed sensitivity and accuracy comparable to contrast-enhanced MRI for detecting residual hepatocellular carcinoma after treatment with lenvatinib and anti–PD-1 antibody therapy. Read more here: https://bit.ly/3YsgqF0